[go: up one dir, main page]

NO20000313D0 - Nye forbindelser - Google Patents

Nye forbindelser

Info

Publication number
NO20000313D0
NO20000313D0 NO20000313A NO20000313A NO20000313D0 NO 20000313 D0 NO20000313 D0 NO 20000313D0 NO 20000313 A NO20000313 A NO 20000313A NO 20000313 A NO20000313 A NO 20000313A NO 20000313 D0 NO20000313 D0 NO 20000313D0
Authority
NO
Norway
Prior art keywords
pct
new connections
sec
date
compounds
Prior art date
Application number
NO20000313A
Other languages
English (en)
Other versions
NO20000313L (no
Inventor
Roger Brown
Garry Pairaudeau
Original Assignee
Astra Pharma Prod
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astra Pharma Prod filed Critical Astra Pharma Prod
Publication of NO20000313D0 publication Critical patent/NO20000313D0/no
Publication of NO20000313L publication Critical patent/NO20000313L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pulmonology (AREA)
  • Vascular Medicine (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Use Of Switch Circuits For Exchanges And Methods Of Control Of Multiplex Exchanges (AREA)
NO20000313A 1997-07-22 2000-01-21 Nye forbindelser NO20000313L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE9702774A SE9702774D0 (sv) 1997-07-22 1997-07-22 Novel compounds
PCT/SE1998/001394 WO1999005144A1 (en) 1997-07-22 1998-07-15 Novel compounds

Publications (2)

Publication Number Publication Date
NO20000313D0 true NO20000313D0 (no) 2000-01-21
NO20000313L NO20000313L (no) 2000-03-22

Family

ID=20407805

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20000313A NO20000313L (no) 1997-07-22 2000-01-21 Nye forbindelser

Country Status (21)

Country Link
US (1) US6166022A (no)
EP (1) EP0998475B1 (no)
JP (1) JP2001510843A (no)
KR (1) KR20010022084A (no)
CN (1) CN1270591A (no)
AT (1) ATE216390T1 (no)
AU (1) AU8370798A (no)
BR (1) BR9811028A (no)
CA (1) CA2296426A1 (no)
DE (1) DE69804966T2 (no)
EE (1) EE200000048A (no)
HU (1) HUP0003826A3 (no)
ID (1) ID25856A (no)
IL (1) IL134111A0 (no)
IS (1) IS5352A (no)
NO (1) NO20000313L (no)
PL (1) PL338181A1 (no)
SE (1) SE9702774D0 (no)
SK (1) SK188299A3 (no)
TR (1) TR200000152T2 (no)
WO (1) WO1999005144A1 (no)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9702773D0 (sv) * 1997-07-22 1997-07-22 Astra Pharma Prod Novel compounds
CA2316264A1 (en) * 1998-02-17 1999-08-19 Brian Springthorpe Novel triazolo(4,5-d)pyrimidine compounds
CA2380656A1 (en) * 1999-09-09 2001-03-15 Nadine Derrien Substituted cyclopentenes, their preparation and their use for chiral scaffolds
SE9904129D0 (sv) * 1999-11-15 1999-11-15 Astra Pharma Prod Novel compounds
US7018985B1 (en) 2000-08-21 2006-03-28 Inspire Pharmaceuticals, Inc. Composition and method for inhibiting platelet aggregation
US7452870B2 (en) * 2000-08-21 2008-11-18 Inspire Pharmaceuticals, Inc. Drug-eluting stents coated with P2Y12 receptor antagonist compound
AR039558A1 (es) * 2000-08-21 2005-02-23 Inspire Pharmaceuticals Inc Composiciones y metodo para el tratamiento de glaucoma o hipertension ocular
US6897201B2 (en) 2000-08-21 2005-05-24 Inspire Pharmaceuticals, Inc. Compositions and methods for the treatment of glaucoma or ocular hypertension
US7115585B2 (en) * 2000-08-21 2006-10-03 Inspire Pharmaceuticals, Inc. Compositions for treating epithelial and retinal tissue diseases
US7132408B2 (en) * 2000-08-21 2006-11-07 Inspire Pharmaceuticals, Inc. Composition and method for inhibiting platelet aggregation
US7435724B2 (en) 2002-02-27 2008-10-14 Inspire Pharmaceutical, Inc. Degradation-resistant mononucleoside phosphate compounds
ATE448222T1 (de) 2003-10-03 2009-11-15 Portola Pharm Inc 2,4-dioxo-3-chinazolinylarylsulfonylharnstoffe
KR20060113699A (ko) 2003-10-03 2006-11-02 포톨라 파마슈티컬스, 인코포레이티드 치환된 이소퀴놀리논
US7749981B2 (en) 2003-10-21 2010-07-06 Inspire Pharmaceuticals, Inc. Drug-eluting stents coated with non-nucleotide P2Y12 receptor antagonist compound
US7504497B2 (en) 2003-10-21 2009-03-17 Inspire Pharmaceuticals, Inc. Orally bioavailable compounds and methods for inhibiting platelet aggregation
US7335648B2 (en) 2003-10-21 2008-02-26 Inspire Pharmaceuticals, Inc. Non-nucleotide composition and method for inhibiting platelet aggregation
AU2004284098B2 (en) 2003-10-21 2009-07-16 Inspire Pharmaceuticals, Inc. Tetrahydro-furo [3,4-d] dioxole compounds and compositions and method for inhibiting platelet aggregation
US7205296B2 (en) 2004-09-29 2007-04-17 Portola Pharmaceuticals, Inc. Substituted 2H-1,3-benzoxazin-4(3H)-ones
US7932376B2 (en) 2005-05-05 2011-04-26 Inspire Pharmaceuticals, Inc. Pyrimidine-based non-nucleotide composition and method for inhibiting platelet aggregation
WO2007020935A1 (ja) * 2005-08-17 2007-02-22 Ono Pharmaceutical Co., Ltd. Ｐ２ｙ１２受容体および／またはｐ２ｙ１４受容体ブロッカーを含有してなる疼痛治療剤
ATE540034T1 (de) 2005-11-03 2012-01-15 Portola Pharm Inc Ä4-(6-halo-7-substituierte-2,4-dioxo-1,4-dihydr - 2h-chinazolin-3-yl)-phenylü-5-chloro-thiophen-2 yl-sulfonylharnstoffe und relevante formen und verfahren
JP2010508350A (ja) * 2006-10-31 2010-03-18 ヤンセン ファーマシューティカ エヌ．ベー． Ａｄｐｐ２ｙ１２レセプターアンタゴニストとしてのトリアゾロピリミジン誘導体
WO2011133871A2 (en) * 2010-04-22 2011-10-27 Alnylam Pharmaceuticals, Inc. 5'-end derivatives
IN2012CN10271A (no) * 2010-05-27 2015-04-10 Reddy’S Lab Ltd Dr
US9458244B2 (en) 2012-12-28 2016-10-04 Abbvie Inc. Single chain multivalent binding protein compositions and methods

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4742064A (en) * 1985-09-10 1988-05-03 Regents Of The University Of Minnesota Antiviral carbocyclic analogs of xylofuranosylpurines
GB8826205D0 (en) * 1988-11-09 1988-12-14 Wellcome Found Heterocyclic compounds
EP0684953A4 (en) * 1993-02-03 1999-12-22 Gensia Inc ADENOSINE KINASE INHIBITORS COMPRISING LYXOFURANOSYL DERIVATIVES.
TR199800019T1 (xx) * 1995-07-11 1998-05-21 Astra Pharmaceuticals Limited Trombosit topaklanmas�n� �nleyici yeni maddeler.

Also Published As

Publication number Publication date
IL134111A0 (en) 2001-04-30
JP2001510843A (ja) 2001-08-07
BR9811028A (pt) 2000-08-01
NO20000313L (no) 2000-03-22
WO1999005144A1 (en) 1999-02-04
CA2296426A1 (en) 1999-02-04
HUP0003826A2 (hu) 2001-04-28
DE69804966T2 (de) 2002-11-07
HUP0003826A3 (en) 2001-11-28
EE200000048A (et) 2000-10-16
DE69804966D1 (de) 2002-05-23
SE9702774D0 (sv) 1997-07-22
CN1270591A (zh) 2000-10-18
ID25856A (id) 2000-11-09
EP0998475A1 (en) 2000-05-10
US6166022A (en) 2000-12-26
TR200000152T2 (tr) 2000-07-21
KR20010022084A (ko) 2001-03-15
SK188299A3 (en) 2000-08-14
IS5352A (is) 2000-01-19
ATE216390T1 (de) 2002-05-15
AU8370798A (en) 1999-02-16
EP0998475B1 (en) 2002-04-17
PL338181A1 (en) 2000-10-09

Similar Documents

Publication Publication Date Title
NO20000313D0 (no) Nye forbindelser
NO20000311D0 (no) Nye forbindelser
IS1904B (is) Hliðstæðar aðferðir við framleiðslu á nýjum (R)-5-karbamóýl-8-flúor-3-N,N-tvíútskiptum-amínó-3,4-díhýdró-2H-1-bensópýrönum
BG103964A (en) SUBSTITUTED PYRAZOLS AS p38 KINASE INHIBITORS
BG101715A (bg) Тетрациклени спиросъединения,метод за тяхното получаване и приложението им като 5нт долу 1d рецепторни антагонисти
YU40300A (sh) Aril fuzirana azapoliciklična jedinjenja
TR200000197T2 (tr) Yeni bileşimler
TR200101398T2 (tr) Pirolidin türevleri-CCR-3 reseptörü antagonistleri.
GEP20084329B (en) 5,7-diaminopyrazolo [4,3-d] pyrimidines useful in the treatment of hypertension
TR200102800T2 (tr) Yeni bileşikler.
IL114599A0 (en) Substituted pyrimidine compounds their preparation and pharmaceutical compositions containing them
SE9702564D0 (sv) New compounds
BR9607335A (pt) Compostos 1-aril-2-acrilamino-etano e seu uso como neuroquinina especialmente antogonistas de neuroquinina 1
SE9702563D0 (sv) Compounds
YU64400A (sh) Aril fuzirana azapoliciklična jedinjenja
RU94039284A (ru) Производные пиперазина, способ их получения, фармкомпозиция и ее использование
NO970473D0 (no) N-substituerte 3-azabicyklo (3.2.0)heptanderivater egnet som neuroleptika
TR200001102T2 (tr) İkameli tetrahidropirimidinen türevleri, üretimleri ve kullanımları.
CA2195747A1 (en) New 3-substituted 3h-2,3-benzodiazepine derivatives, their preparation and use as medicaments
BG101328A (en) New derivatives of imidazoloquinaxalon with heterocyclic substituents, their preparation and use
PT1025101E (pt) Derivados de nafto-imidazo¬1,2-a|piridina sua preparacao e uso no tratamento de perturbacoes do sistema nervoso central
SE0004099D0 (sv) Novel compounds
MY133140A (en) N-substituted azabicycloheptane derivatives, their preparation and use
MY136138A (en) Hexacyclic compounds
DE69907448D1 (de) Pyrido[2,3-b]indolizinderivate und aza analoge: crf1 spezifische liganden

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application